Keystone Malaria Symposium 2022: a vibrant discussion of progress made and challenges ahead from drug discovery to treatment.

Autor: Kanai M; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: mk3593@cumc.columbia.edu., Hagenah LM; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: lmh2220@cumc.columbia.edu., Ashley EA; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Laos. Electronic address: liz@tropmedres.ac., Chibale K; Drug Discovery and Development (H3D) Centre, University of Cape Town, Rondebosch, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa; South African Medical Research Council Drug Discovery and Development Research Unit, University of Cape Town, Rondebosch, South Africa; Department of Chemistry, University of Cape Town, Rondebosch, South Africa. Electronic address: kelly.chibale@uct.ac.za., Fidock DA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA; Center for Malaria Therapeutics and Antimicrobial Resistance, Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: df2260@cumc.columbia.edu.
Jazyk: angličtina
Zdroj: Trends in parasitology [Trends Parasitol] 2022 Sep; Vol. 38 (9), pp. 711-718. Date of Electronic Publication: 2022 Jul 18.
DOI: 10.1016/j.pt.2022.06.005
Databáze: MEDLINE